Exogenous gene expression in recombinant adenovirus for minimal impact on viral kinetics
AssigneeThe Salk Institute for Biological Studies
InventorsClodagh O'Shea, William Partlo, Colin Powers
Life of this patent
Estimating the term…
Abstract
Recombinant adenovirus genomes that include an exogenous open reading frame (ORF) and a self-cleaving peptide coding sequence are described. Optimal placement of the exogenous genes for minimal impact on viral kinetics is further disclosed. Therapeutic applications of the recombinant adenoviruses are also described.
Claims35
A recombinant adenovirus genome, comprising a heterologous open reading frame (ORF) and a self-cleaving peptide coding sequence, both operably linked to and in the same reading frame as an endogenous adenovirus ORF, wherein the self-cleaving peptide coding sequence is located between the heterologous ORF and the endogenous ORF, and wherein:
- the endogenous ORF is E1B-55k and the heterologous ORF is 3′ of E1B-55k;
- the endogenous ORF is DNA polymerase and the heterologous ORF is 5′ of DNA polymerase;
- the endogenous ORF is DNA-binding protein (DBP) and the heterologous ORF is 3′ of DBP;
- the endogenous ORF is adenovirus death protein (ADP) and the heterologous ORF is 5′ of ADP;
- the endogenous ORF is E3-14.7k and the heterologous ORF is 3′ of E3-14.7k;
- the endogenous ORF is E4-ORF2 and the heterologous ORF is 5′ of E4-ORF2;
- or
- the endogenous ORF is fiber and the heterologous ORF is 3′ of fiber.
Dependencies are inferred from the claim text.